3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition

US7119093B2 · kind B2 · utility

Assignee

• BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

• Gerald Juergen Roth · Biberach, DE
• Guenter Linz · Mittelbiberach, DE
• Peter Sieger · Mittelbiberach, DE
• Werner Rall · Mittelbiberach, DE
• Frank Hilberg · Wien, AT
• Thomas Bock · Mont de Marsan, FR

Key dates

• Filing date: Jul 21, 2003
• Grant date: Oct 10, 2006
• Expiry date: Feb 21, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to the compound 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycabonyl-2-indolinone-monoethanesulphonate of formula I and the use thereof as a pharmaceutical composition